Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL521 (Aches-n-pain, Advil, Advil liqui-gels, Advil migraine liqui-gels, Anadin joint pain, Anadin liquifast, Anadin period pain relief, Anadin ultra, Apsifen, Apsifen-f, Arthrofen 200, Arthrofen 400, Arthrofen 600, Brufen ret, Burana, Caldolor, Cap-profen, Children's advil, Children's advil-flavored, Children's elixsure, Children's ibuprofen, Children's motrin, Codafen continus, Co-op, Cuprofen for child, Cuprofen plus, Deep relief, Ebufac, Femafen, Fenbid, Fenbid fte, Fenpaed, Feverfen, Fleximex, IB-100, Ibucalm, Ibuderm, Ibufac, Ibugel, Ibugel fte, Ibular, Ibuleve, Ibumed, Ibumetin, Ibumousse, Ibuprin, Ibuprofen, Ibuprofenum, Ibuprohm, Ibu-slo, Ibuspray, Ibu-tab, Ibu-tab 200, Ibutime, Inabrin, Infant's advil, Inoven, IP-82, Isisfen, Junifen, Junior strength advil, Junior strength ibuprofen, Junior strength motrin, Lidifen, Lidifen-f, Lobufen, M01AE01, Mandafen, Manorfen, Maxa-gesic, Medipren, Midol, Midol liquid gels, Migrafen, Motrin, Motrin ib, Motrin migraine pain, Novaprin, NSC-256857, Nuprin, Nurofen 400, Nurofen back pain sr, Nurofen child, Nurofen for child, Nurofen plus, Nurofen recovery, Nurofen sinus, Nurofen solb, Orbifen, Pacifene, Paxofen, Pedea, Pediatric advil, Phensic, Phor pain, Phorpain, Phorpain max strgh, Profen, Proflex, Proflex sr, RD 13621, Relcofen, Rimafen, Rufen, Seclodin, Suspren, Tab-profen, U-18,573, U-18573) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
AKR1C3/Aldo-keto-reductase family 1 member C3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4681] [GtoPdb: 1382] [UniProtKB: P42330] | ||||||||
ChEMBL | Inhibition of recombinant human AKR1C3 | B | 4.48 | pIC50 | 33000 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 5170-5175 [PMID:16183274] |
ChEMBL | Inhibition of AKR1C3 (unknown origin) | B | 5 | pIC50 | 10000 | nM | IC50 | Medchemcomm (2018) 9: 969-981 [PMID:30108986] |
5-LOX/Arachidonate 5-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL215] [GtoPdb: 1385] [UniProtKB: P09917] | ||||||||
ChEMBL | Inhibitory activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay | F | 4.77 | pIC50 | 17000 | nM | IC50 | J Med Chem (1997) 40: 819-824 [PMID:9057869] |
5-LOX/Arachidonate 5-lipoxygenase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL312] [GtoPdb: 1385] [UniProtKB: P12527] | ||||||||
ChEMBL | Inhibition of 5-LOX in RBL1 cells assessed as reduction in LTB4 production using A23187-induced arachidonic acid as substrate preincubated for 2 hrs followed by A23187 addition measured after 15 mins by LC-MS/MS analysis | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2017) 8: 864-868 [PMID:28835803] |
ChEMBL | Inhibitory activity against 5-lipoxygenase catalysis (5-LO) in sonicated rat basophilic leukemia cell lysate | F | 4.85 | pIC50 | 14000 | nM | IC50 | J Med Chem (1997) 40: 819-824 [PMID:9057869] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Inhibition of human recombinant COX1 expressed in Sf9 cells using arachidonic acid and ADHP incubated for 3 mins by fluorimetry | B | 4.47 | pIC50 | 34000 | nM | IC50 | J Med Chem (2020) 63: 12614-12622 [PMID:32931274] |
ChEMBL | Inhibition of PGHS1 assessed as conversion of arachidonic acid to prostaglandin | B | 4.6 | pIC50 | 25000 | nM | IC50 | J Nat Prod (1999) 62: 294-296 [PMID:10075763] |
ChEMBL | Inhibition of COX1-catalyzed prostaglandin biosynthesis 10 mins of preincubation | B | 4.74 | pIC50 | 18000 | nM | IC50 | J Nat Prod (1998) 61: 1212-1215 [PMID:9784154] |
ChEMBL | Inhibition activity against recombinant human Prostaglandin G/H synthase 1 | B | 4.95 | pIC50 | 11100 | nM | IC50 | J Med Chem (1997) 40: 819-824 [PMID:9057869] |
ChEMBL | Inhibition of COX1 in human whole blood after 15 mins | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg Med Chem (2007) 15: 4876-4890 [PMID:17517512] |
ChEMBL | Compound was evaluated for inhibition of Prostaglandin G/H synthase 1 | B | 5.2 | pIC50 | 6300 | nM | IC50 | Bioorg Med Chem Lett (1996) 6: 707-712 |
GtoPdb | - | - | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (1998) 41: 1124-37 [PMID:9544212] |
ChEMBL | Inhibition of Prostaglandin G/H synthase 1 (COX-1). | B | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (1998) 41: 1124-1137 [PMID:9544212] |
ChEMBL | Concentration (in uM) to inhibit 50% of Prostaglandin G/H synthase 1 (COX-1) and is expressed in IC50. | B | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (1998) 41: 1112-1123 [PMID:9544211] |
ChEMBL | Inhibitory activity against prostaglandin G/H synthase 1 (COX-1) | B | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (1998) 41: 3515-3529 [PMID:9719605] |
ChEMBL | Inhibition of COX-1 (unknown origin) using arachidonic acid as substrate measured after 10 mins by fluorometric based multimode microplate reader | B | 5.57 | pIC50 | 2704 | nM | IC50 | Eur J Med Chem (2021) 209: 112918-112918 [PMID:33071054] |
ChEMBL | Inhibition of COX-1 in human washed platelet assessed as inhibition of 10 uM arachidonic acid-induced TXB2 formation incubated for 25 mins prior to arachidonic acid challenge measured after 30 mins by radioimmunoassay | B | 5.73 | pIC50 | 1860 | nM | IC50 | J Med Chem (2013) 56: 4277-4299 [PMID:23651359] |
ChEMBL | Inhibition of COX-1 in human washed platelet assessed as inhibition of 0.5 uM arachidonic acid-induced TXB2 formation incubated for 25 mins prior to arachidonic acid challenge measured after 30 mins by radioimmunoassay | B | 6.54 | pIC50 | 290 | nM | IC50 | J Med Chem (2013) 56: 4277-4299 [PMID:23651359] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 6.67 | pIC50 | 212 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Cyclooxygenase-1 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2860] [UniProtKB: O62664] | ||||||||
ChEMBL | Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production preincubated for 10 mins | B | 4.74 | pIC50 | 18000 | nM | IC50 | J Nat Prod (1998) 61: 2-7 [PMID:9461646] |
ChEMBL | Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production | B | 4.89 | pIC50 | 13000 | nM | IC50 | J Nat Prod (1998) 61: 2-7 [PMID:9461646] |
ChEMBL | Inhibition of bovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | J Med Chem (2009) 52: 1525-1529 [PMID:19296694] |
ChEMBL | Inhibition of bovine COX-1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 6855-6861 [PMID:19884005] |
Cyclooxygenase-1 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2949] [UniProtKB: P05979] | ||||||||
ChEMBL | Inhibition of sheep placental cotyledons COX1 | B | 5.05 | pKi | 9000 | nM | Ki | J Med Chem (2011) 54: 8555-8562 [PMID:22091869] |
ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate pretreated for 3 mins followed by substrate addition measured immediately | B | 4.14 | pIC50 | 72800 | nM | IC50 | J Nat Prod (2017) 80: 2472-2477 [PMID:28885836] |
ChEMBL | Competitive inhibition of ovine COX-1 assessed as reduction in PGE2 production using 6250 nM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 4.15 | pIC50 | 70100 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of ovine COX-1 assessed as decrease in PGH2 production using arachidonic acid as substrate treated with enzyme for 10 mins prior to substrate challenge for 2 mins by enzyme immunoassay | B | 4.59 | pIC50 | 26000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1958-1962 [PMID:24656662] |
ChEMBL | Inhibitory concentration against Prostaglandin G/H synthase 1 of ram seminal vesicles at 100 uM | B | 4.84 | pIC50 | 14400 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 1793-1797 [PMID:15780608] |
ChEMBL | Inhibition of ovine COX-1 assessed as residual activity by measuring formation of 12-HHT from arachidonic acid by HPLC analysis | B | 4.92 | pIC50 | 12000 | nM | IC50 | Bioorg Med Chem (2011) 19: 5372-5382 [PMID:21873070] |
ChEMBL | Inhibition of ovine COX1 after 5 mins | B | 4.92 | pIC50 | 12000 | nM | IC50 | J Med Chem (2010) 53: 4691-4700 [PMID:20503989] |
ChEMBL | Inhibition of purified ovine COX1 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 5 | pIC50 | 10100 | nM | IC50 | ACS Med Chem Lett (2014) 5: 983-988 [PMID:25221653] |
ChEMBL | Inhibition of Ovine COX-1 preincubated for 15 mins by fluorescence analysis | B | 5 | pIC50 | >10000 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1086-1090 [PMID:26487917] |
ChEMBL | Tested for inhibitory activity against Prostaglandin G/H synthase 1 from ovine | B | 5.05 | pIC50 | 9000 | nM | IC50 | J Med Chem (1995) 38: 3895-3901 [PMID:7562922] |
ChEMBL | Inhibition of ram seminal vesicle COX1 assessed as reduction in PGE2 formation pre-incubated for 5 mins before arachidonic acid addition and measured after 20 mins by ELISA | B | 5.2 | pIC50 | 6300 | nM | IC50 | J Nat Prod (2017) 80: 999-1006 [PMID:28322565] |
ChEMBL | Inhibition of ovine COX1 pre-incubated for 10 mins before arachidonic acid substrate addition by enzyme immunoassay | B | 5.3 | pIC50 | 5000 | nM | IC50 | J Med Chem (2012) 55: 8807-8826 [PMID:23043222] |
ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 2 mins by fluorescence based enzyme immunoassay | B | 5.39 | pIC50 | 4120 | nM | IC50 | Eur J Med Chem (2019) 180: 86-98 [PMID:31301566] |
ChEMBL | Inhibition of ovine COX-1 | B | 5.4 | pIC50 | 4000 | nM | IC50 | J Med Chem (2011) 54: 1356-1364 [PMID:21280601] |
ChEMBL | Competitive inhibition of ovine COX-1 assessed as reduction in PGE2 production using 250 nM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 5.4 | pIC50 | 4000 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 6074-6080 [PMID:21890358] |
ChEMBL | Inhibition of ovine COX1 | B | 5.54 | pIC50 | 2900 | nM | IC50 | J Med Chem (2012) 55: 688-696 [PMID:22148253] |
ChEMBL | Inhibition of ovine COX1 | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 163-168 [PMID:23200247] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem (2007) 15: 4767-4774 [PMID:17509888] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 406-412 [PMID:26691756] |
ChEMBL | In vitro inhibitory concentration against COX-1 enzyme | B | 5.54 | pIC50 | 2900 | nM | IC50 | J Med Chem (2005) 48: 4061-4067 [PMID:15943479] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem (2008) 16: 9694-9698 [PMID:18930406] |
ChEMBL | Inhibition of ovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 3014-3018 [PMID:19419861] |
ChEMBL | Inhibition of ovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem (2009) 17: 5182-5188 [PMID:19500994] |
ChEMBL | Inhibition of ovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1324-1329 [PMID:20097072] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 896-902 [PMID:20045320] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2168-2173 [PMID:20202839] |
ChEMBL | Inhibition of sheep COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 4544-4549 [PMID:20576432] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3951-3956 [PMID:21641217] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 584-588 [PMID:19136259] |
ChEMBL | Inhibition of ovine COX-1 assessed as reduction in PGE2 production using 10 uM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 5.66 | pIC50 | 2190 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of ovine COX1 assessed as reduction in Prostaglandin production by enzyme immunoassay | B | 5.85 | pIC50 | 1420 | nM | IC50 | Bioorg Med Chem (2018) 26: 891-902 [PMID:29373271] |
ChEMBL | Reversible competitive inhibition of prostaglandin G/H synthase 1 | B | 5.97 | pIC50 | 1060 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 667-671 [PMID:14741265] |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of human recombinant COX-2 assessed as residual activity by measuring formation of 12-HHT from arachidonic acid by HPLC analysis | B | 4.1 | pIC50 | 80000 | nM | IC50 | Bioorg Med Chem (2011) 19: 5372-5382 [PMID:21873070] |
ChEMBL | Inhibition of human recombinant COX2 after 5 mins | B | 4.1 | pIC50 | 80000 | nM | IC50 | J Med Chem (2010) 53: 4691-4700 [PMID:20503989] |
ChEMBL | Inhibition of human COX2 pre-incubated for 10 mins before substrate addition by enzyme immunoassay | B | 4.44 | pIC50 | 36000 | nM | IC50 | J Med Chem (2012) 55: 8807-8826 [PMID:23043222] |
ChEMBL | Inhibitory activity against prostaglandin G/H synthase 2 (COX-2) | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (1998) 41: 3515-3529 [PMID:9719605] |
ChEMBL | Concentration (in uM) to inhibit 50% of Prostaglandin G/H synthase 2 (COX-2) and is expressed in IC50. | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (1998) 41: 1112-1123 [PMID:9544211] |
ChEMBL | Inhibition of Prostaglandin G/H synthase 2 (COX-2). | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (1998) 41: 1124-1137 [PMID:9544212] |
ChEMBL | Inhibition of human recombinant COX-2 assessed as decrease in PGH2 production using arachidonic acid as substrate treated with enzyme for 10 mins prior to substrate challenge for 2 mins by enzyme immunoassay | B | 4.52 | pIC50 | 30000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1958-1962 [PMID:24656662] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | B | 4.59 | pIC50 | 25530 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Inhibition of COX2 (unknown origin) | B | 4.84 | pIC50 | 14500 | nM | IC50 | Eur J Med Chem (2017) 138: 1002-1033 [PMID:28759875] |
ChEMBL | Inhibition of recombinant human COX2 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 2 mins by fluorescence based enzyme immunoassay | B | 5.05 | pIC50 | 8910 | nM | IC50 | Eur J Med Chem (2019) 180: 86-98 [PMID:31301566] |
ChEMBL | Tested for inhibitory activity against Prostaglandin G/H synthase 2 from human | B | 5.1 | pIC50 | 8000 | nM | IC50 | J Med Chem (1995) 38: 3895-3901 [PMID:7562922] |
ChEMBL | Inhibition of COX2 in human whole blood after 15 mins | B | 5.21 | pIC50 | 6200 | nM | IC50 | Bioorg Med Chem (2007) 15: 4876-4890 [PMID:17517512] |
ChEMBL | Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate incubated for 5 to 10 mins by fluorometric analysis | B | 5.27 | pIC50 | 5330 | nM | IC50 | RSC Med Chem (2022) 13: 471-496 [PMID:35685617] |
ChEMBL | Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate measured after 10 mins by fluorometric based multimode microplate reader | B | 5.27 | pIC50 | 5326 | nM | IC50 | Eur J Med Chem (2021) 209: 112918-112918 [PMID:33071054] |
ChEMBL | Inhibition of human recombinant COX2 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 5.37 | pIC50 | 4300 | nM | IC50 | ACS Med Chem Lett (2014) 5: 983-988 [PMID:25221653] |
ChEMBL | Inhibition of human recombinant COX2 assessed as reduction in PGE2 formation pre-incubated for 5 mins before arachidonic acid addition and measured after 20 mins by ELISA | B | 5.38 | pIC50 | 4200 | nM | IC50 | J Nat Prod (2017) 80: 999-1006 [PMID:28322565] |
ChEMBL | Inhibition of human recombinant COX2 expressed in Sf9 cells using arachidonic acid and ADHP incubated for 5 mins by fluorimetry | B | 5.48 | pIC50 | 3300 | nM | IC50 | J Med Chem (2020) 63: 12614-12622 [PMID:32931274] |
ChEMBL | Inhibition of human recombinant COX-2 assessed as reduction in PGE2 production using 10 uM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 5.48 | pIC50 | 3300 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of human recombinant COX2 assessed as reduction in PGE2 production using arachidonic acid substrate by ELISA | B | 5.7 | pIC50 | 2000 | nM | IC50 | J Nat Prod (2019) 82: 1839-1848 [PMID:31268709] |
ChEMBL | Inhibition of COX2 (unknown origin) assessed as reduction in PGF2alpha content using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition and measured after 2 mins by enzyme immunoassay | B | 5.75 | pIC50 | 1790 | nM | IC50 | J Med Chem (2022) 65: 14916-14937 [PMID:36282007] |
ChEMBL | Inhibition of human recombinant COX-2 | B | 5.85 | pIC50 | 1400 | nM | IC50 | J Med Chem (2011) 54: 1356-1364 [PMID:21280601] |
ChEMBL | Inhibition of human COX2 expressed in baculovirus system | B | 5.87 | pIC50 | 1350 | nM | IC50 | J Med Chem (2011) 54: 8555-8562 [PMID:22091869] |
GtoPdb | - | - | 5.87 | pIC50 | 1350 | nM | IC50 | J Med Chem (2011) 54: 8555-62 [PMID:22091869] |
ChEMBL | Inhibition of human recombinant COX-2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 6855-6861 [PMID:19884005] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3951-3956 [PMID:21641217] |
ChEMBL | Inhibition of human COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 4544-4549 [PMID:20576432] |
ChEMBL | Inhibition of human recombinant COX2 | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2012) 55: 688-696 [PMID:22148253] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2168-2173 [PMID:20202839] |
ChEMBL | Inhibition of human recombinant COX2 | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 163-168 [PMID:23200247] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1324-1329 [PMID:20097072] |
ChEMBL | Inhibition of recombinant human COX-2 preincubated for 15 mins by fluorescence analysis | B | 5.96 | pIC50 | 1100 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1086-1090 [PMID:26487917] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 406-412 [PMID:26691756] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem (2009) 17: 5182-5188 [PMID:19500994] |
ChEMBL | Inhibition of recombinant human N-terminal His-tagged COX2 expressed in baculovirus infected Sf21 cells assessed as reduction in prostaglandin production by enzyme immunoassay | B | 5.97 | pIC50 | 1080 | nM | IC50 | Bioorg Med Chem (2018) 26: 891-902 [PMID:29373271] |
ChEMBL | Inhibition activity against recombinant human Prostaglandin G/H synthase 2 | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (1997) 40: 819-824 [PMID:9057869] |
Cyclooxygenase-2 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3331] [UniProtKB: O62698] | ||||||||
ChEMBL | Inhibition of bovine COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2009) 52: 1525-1529 [PMID:19296694] |
Cyclooxygenase-2 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4102] [UniProtKB: P79208] | ||||||||
ChEMBL | Inhibition of sheep placental cotyledons COX2 | B | 5.05 | pKi | 9000 | nM | Ki | J Med Chem (2011) 54: 8555-8562 [PMID:22091869] |
ChEMBL | Inhibition of ovine COX2 assessed as reduction in PGH2 production by enzyme immunoassay | B | 5.85 | pIC50 | 1400 | nM | IC50 | Bioorg Med Chem (2018) 26: 4113-4126 [PMID:29980364] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem (2007) 15: 4767-4774 [PMID:17509888] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem (2008) 16: 9694-9698 [PMID:18930406] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 584-588 [PMID:19136259] |
ChEMBL | In vitro inhibitory concentration against COX-2 enzyme | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2005) 48: 4061-4067 [PMID:15943479] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 896-902 [PMID:20045320] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 6074-6080 [PMID:21890358] |
ChEMBL | Inhibition of ovine COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 3014-3018 [PMID:19419861] |
COX-2 /Cyclooxygenase-2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4321] [GtoPdb: 1376] [UniProtKB: Q05769] | ||||||||
ChEMBL | Inhibition of COX-2 in mouse RAW264.7 cells assessed as decrease in LPS-induced PGE2 production treated prior to LPS challenge by enzyme immunoassay | B | 6.07 | pIC50 | 860 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1958-1962 [PMID:24656662] |
Dehydrogenase/reductase SDR family member 9 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075220] [UniProtKB: Q8VD48] | ||||||||
ChEMBL | Inhibition of rat liver 3-alpha-HSD assessed as 5-beta-dihydrocortisone reduction | B | 4 | pIC50 | 100000 | nM | IC50 | Bioorg Med Chem (2007) 15: 4876-4890 [PMID:17517512] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis | B | 5 | pIC50 | >10000 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1086-1090 [PMID:26487917] |
fatty acid binding protein 1/Fatty acid-binding protein, liver in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5738] [GtoPdb: 2531] [UniProtKB: P02692] | ||||||||
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 4.32 | pKi | 47600 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
L-PGDS/Prostaglandin-H2 D-isomerase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4334] [GtoPdb: 1380] [UniProtKB: O09114] | ||||||||
ChEMBL | Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes | B | 4.89 | pIC50 | 13000 | nM | IC50 | J Med Chem (1991) 34: 1099-1110 [PMID:1900533] |
Serum albumin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3253] [UniProtKB: P02768] | ||||||||
ChEMBL | Binding affinity to human serum albumin assessed as dissociation constant and measured after 5 mins by MST assay | B | 4.14 | pKd | 73000 | nM | Kd | J Med Chem (2022) 65: 710-733 [PMID:34939412] |
Serum albumin in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3728] [UniProtKB: P02769] | ||||||||
ChEMBL | Binding affinity to bovine serum albumin | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg Med Chem (2008) 16: 1162-1173 [PMID:18024138] |
OAT6/Solute carrier family 22 member 20 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5269] [GtoPdb: 1037] [UniProtKB: Q80UJ1] | ||||||||
ChEMBL | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr | B | 5.95 | pKi | 1122.02 | nM | Ki | J Biol Chem (2007) 282: 23841-23853 [PMID:17553798] |
ChEMBL | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr | B | 5.96 | pKi | 1100 | nM | Ki | J Biol Chem (2007) 282: 23841-23853 [PMID:17553798] |
Organic anion transporter 1/Solute carrier family 22 member 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1641347] [GtoPdb: 1025] [UniProtKB: Q4U2R8] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of Adefovir uptake in OAT1-expressing CHO cells | F | 5.1 | pIC50 | 8000 | nM | IC50 | J Pharmacol Exp Ther (2000) 295: 10-15 [PMID:10991954] |
Organic anion transporter 1/Solute carrier family 22 member 6 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5653] [GtoPdb: 1025] [UniProtKB: Q8VC69] | ||||||||
ChEMBL | Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr | B | 5.33 | pKi | 4700 | nM | Ki | J Biol Chem (2007) 282: 23841-23853 [PMID:17553798] |
ChEMBL | Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr | B | 5.33 | pKi | 4677.35 | nM | Ki | J Biol Chem (2007) 282: 23841-23853 [PMID:17553798] |
Organic anion transporter 1/Solute carrier family 22 member 6 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1777665] [GtoPdb: 1025] [UniProtKB: O35956] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of PAH uptake in Xenopus laevis oocytes | F | 5.46 | pKi | 3500 | nM | Ki | Mol Pharmacol (1999) 55: 847-854 [PMID:10220563] |
ASIC1 in Human [GtoPdb: 684] [UniProtKB: P78348] | ||||||||
GtoPdb | - | - | 3.5 | pIC50 | ~350000 | nM | IC50 |
J Neurosci (2001) 21: 8026-33 [PMID:11588175]; J Med Chem (2017) 60: 8192-8200 [PMID:28949138] |
SMCT1 in Human [GtoPdb: 922] [UniProtKB: Q8N695] | ||||||||
GtoPdb | - | - | 4.2 | pIC50 | 63095 | nM | IC50 | Pharm Res (2006) 23: 1209-16 [PMID:16729224] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]